GB202101543D0 - Vaping e-liquid composition and the use thereof - Google Patents

Vaping e-liquid composition and the use thereof

Info

Publication number
GB202101543D0
GB202101543D0 GBGB2101543.3A GB202101543A GB202101543D0 GB 202101543 D0 GB202101543 D0 GB 202101543D0 GB 202101543 A GB202101543 A GB 202101543A GB 202101543 D0 GB202101543 D0 GB 202101543D0
Authority
GB
United Kingdom
Prior art keywords
vaping
liquid composition
composition
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2101543.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thirty Respiratory Ltd
Original Assignee
Thirty Respiratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thirty Respiratory Ltd filed Critical Thirty Respiratory Ltd
Priority to GBGB2101543.3A priority Critical patent/GB202101543D0/en
Publication of GB202101543D0 publication Critical patent/GB202101543D0/en
Priority to PCT/GB2022/050279 priority patent/WO2022167797A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0266Nitrogen (N)
    • A61M2202/0275Nitric oxide [NO]
GBGB2101543.3A 2021-02-04 2021-02-04 Vaping e-liquid composition and the use thereof Ceased GB202101543D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2101543.3A GB202101543D0 (en) 2021-02-04 2021-02-04 Vaping e-liquid composition and the use thereof
PCT/GB2022/050279 WO2022167797A1 (en) 2021-02-04 2022-02-03 Vaping e-liquid composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2101543.3A GB202101543D0 (en) 2021-02-04 2021-02-04 Vaping e-liquid composition and the use thereof

Publications (1)

Publication Number Publication Date
GB202101543D0 true GB202101543D0 (en) 2021-03-24

Family

ID=74878996

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2101543.3A Ceased GB202101543D0 (en) 2021-02-04 2021-02-04 Vaping e-liquid composition and the use thereof

Country Status (2)

Country Link
GB (1) GB202101543D0 (en)
WO (1) WO2022167797A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507099A (en) 1994-02-21 1997-09-16 Aberden University Dosage form sterilization method sterilizing composition and animal food supplement comprising acidified nitrite as an anti-microbial agent
GB0022084D0 (en) 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US8790715B2 (en) * 2006-02-16 2014-07-29 Ino Therapeutics Llc Method and apparatus for generating nitric oxide for medical use
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
ITMI20130214A1 (en) * 2013-02-15 2014-08-16 Pharmaday S R L COMPOSITION FOR ELECTRONIC CIGARETTE
US20150072023A1 (en) * 2013-09-11 2015-03-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2020176791A1 (en) * 2019-02-28 2020-09-03 Nano Vape Corporation Nitric oxide releasing vaping formulations, compounds, use, and methods of forming
WO2020205676A1 (en) * 2019-03-29 2020-10-08 V Rush Vapes LLC Composition of athletic and fitness supplements, method for production and method for pulmonary administration of same
JP2023510662A (en) 2019-06-04 2023-03-15 サーティー レスピラトリー リミテッド Methods and compositions for producing nitric oxides and their use for delivering nitric oxides through the respiratory tract

Also Published As

Publication number Publication date
WO2022167797A1 (en) 2022-08-11

Similar Documents

Publication Publication Date Title
GB2576389B (en) Refrigerant composition and use thereof
GB202106282D0 (en) Composition and use thereof
EP4063489A4 (en) Composition and use thereof
SG11202107687VA (en) Prebiotic composition and its use
SG11202102182VA (en) Desiccant composition and use thereof
IL289531A (en) Cd38-binding agents and uses thereof
IL285916A (en) Novel compositions and use thereof
IL288828A (en) Cd38-binding agents and uses thereof
EP4121031A4 (en) 3-diarylmethylenes and uses thereof
GB202215746D0 (en) Terpenophenolic compounds and their use
GB202101543D0 (en) Vaping e-liquid composition and the use thereof
GB202002010D0 (en) Microtopographies and uses thereof
GB201901413D0 (en) Compositions and their use
GB202102228D0 (en) Composition and use thereof
GB202014427D0 (en) Composition and use
GB201907591D0 (en) Composition and use
GB202107254D0 (en) Compositions and use thereof
GB202106861D0 (en) Composition and uses
EP4090159A4 (en) Pyrazolylpyrimidines and use thereof
AU2019903320A0 (en) Composition and use thereof
AU2019903321A0 (en) Composition and use thereof
GB201815215D0 (en) Composition and use
SG11202103490RA (en) Galactose oral composition and use thereof
AU2021902949A0 (en) Composition and use thereof
GB201815546D0 (en) Composition and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)